Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant
Z. Zakaria, A. Tivnan, L. Flanagan, D. W. Murray, M. Salvucci, B. W. Stringer, B. W. Day, A. W. Boyd, D. Kögel, M. Rehm, D. F. O'Brien, A. T. Byrne, J. H.M. Prehn
Research output: Contribution to journal › Article › peer-review
15Citations
(Scopus)
3Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant'. Together they form a unique fingerprint.